Bionik Laboratories Corp
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; In… Read more
Bionik Laboratories Corp (BNKL) - Total Assets
Latest total assets as of March 2023: $3.36 Million USD
Based on the latest financial reports, Bionik Laboratories Corp (BNKL) holds total assets worth $3.36 Million USD as of March 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bionik Laboratories Corp - Total Assets Trend (2011–2023)
This chart illustrates how Bionik Laboratories Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bionik Laboratories Corp - Asset Composition Analysis
Current Asset Composition (March 2023)
Bionik Laboratories Corp's total assets of $3.36 Million consist of 82.6% current assets and 17.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.7% |
| Accounts Receivable | $453.08K | 13.5% |
| Inventory | $1.03 Million | 30.8% |
| Property, Plant & Equipment | $442.32K | 13.2% |
| Intangible Assets | $34.00K | 1.0% |
| Goodwill | $99.55K | 3.0% |
Asset Composition Trend (2011–2023)
This chart illustrates how Bionik Laboratories Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bionik Laboratories Corp's current assets represent 82.6% of total assets in 2023, a decrease from 100.0% in 2011.
- Cash Position: Cash and equivalents constituted 12.7% of total assets in 2023, down from 99.0% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is inventory at 30.8% of total assets.
Bionik Laboratories Corp Competitors by Total Assets
Key competitors of Bionik Laboratories Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Bionik Laboratories Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Bionik Laboratories Corp generates 0.54x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Bionik Laboratories Corp is currently not profitable relative to its asset base.
Bionik Laboratories Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.20 | 3.07 | 0.39 |
| Quick Ratio | 0.75 | 2.27 | 0.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $468.38K | $ 3.09 Million | $ -3.15 Million |
Bionik Laboratories Corp - Advanced Valuation Insights
This section examines the relationship between Bionik Laboratories Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.04 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -28.1% |
| Total Assets | $3.36 Million |
| Market Capitalization | $370.65 USD |
Valuation Analysis
Below Book Valuation: The market values Bionik Laboratories Corp's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Bionik Laboratories Corp's assets decreased by 28.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Bionik Laboratories Corp (2011–2023)
The table below shows the annual total assets of Bionik Laboratories Corp from 2011 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-03-31 | $3.36 Million | -28.10% |
| 2022-03-31 | $4.68 Million | -46.78% |
| 2021-03-31 | $8.79 Million | -52.55% |
| 2020-03-31 | $18.52 Million | -39.64% |
| 2019-03-31 | $30.68 Million | +7.32% |
| 2018-03-31 | $28.58 Million | -1.33% |
| 2017-03-31 | $28.97 Million | +364.49% |
| 2016-03-31 | $6.24 Million | -13.84% |
| 2015-12-31 | $7.24 Million | +223170.05% |
| 2015-03-31 | $3.24K | -26.68% |
| 2014-03-31 | $4.42K | -10.65% |
| 2013-03-31 | $4.95K | -60.26% |
| 2012-03-31 | $12.46K | +56.98% |
| 2011-03-31 | $7.93K | -- |